Restless Legs Syndrome (RLS) is a common sleep disorder, but there is a paucity of large cohort studies examining the association of RLS with clinical outcomes including all-cause mortality, incident coronary heart disease (CHD), stroke and chronic kidney disease (CKD).
Introduction
Restless legs syndrome (RLS) was described in the late 17th century by Sir Thomas Willis and was named RLS by Ekbom in the middle of the last century. (Ekbom, 1960) RLS is characterized by an urge to move the legs that is often hard to resist and is usually but not always associated with disagreeable leg sensations. The symptoms occur during inactivity and may interfere with sleep, are worse in the evening and night with significant relief in the morning. (Ekbom, 1960) Clinical diagnostic criteria for RLS have been established by the International RLS Study Group (IRLSSG) and have recently been modified. The prevalence of RLS is estimated to be between 0.1% and 15% in the general population. (Stiasny K, 2002 , Nichols et al., 2003 , Tan et al., 2001 , Lavigne and Montplaisir, 1994 , Phillips et al., 2000 In the general population, four previous studies assessed the association between RLS and mortality and reported contradictory results. ( Patients with RLS have also been reported to have a higher risk of stroke and heart disease than those without the disorder. (Elwood et al., 2006 , Li et al., 2012 In the Nurses' Health Study, the women who reported more than 3 years of RLS history had higher risk of coronary heart disease (CHD) and non fatal myocardial infarct (MI). (Li et al., 2012) However, this study was subject to recall bias. In a prospective population study of almost 2,000 men, and with 10-year follow-up, RLS was associated with a 67 % increase in the relative odds for stroke compared to subjects without RLS. (Elwood et al., 2006) Contrary to the findings from these studies, Winter et al. reported no association between RLS and CHD and MI in women. (Winter et al., 2012) In addition, Szentkiralyi et al. used two cohorts' data and reported no association between RLS and CHD and stroke. (Szentkiralyi et al., 2013) However, most of these studies were limited by a low number of events.
In patients with chronic kidney disease (CKD) and end stage renal disease (ESRD) the predictors and outcomes of RLS are well documented, ( Given that the previous studies reported contradictory results and were limited by low numbers of events, we examined the associations of incident RLS with all-cause mortality, the incidences of coronary heart disease, ischemic stroke, and CKD in a large, nationally representative contemporary cohort of US veterans. Based on previous findings, we hypothesized that RLS is associated with higher risks of these adverse clinical outcomes.
Methods

Study Setting and Cohort Definition
The institutional review committees at the Memphis and Long Beach Veterans Affairs Medical Centers approved the study. Given the large sample size, anonymity of the patients studied, and nonintrusive nature of the research, the requirement for written consent was waived. Data were obtained from the Racial and Cardiovascular Risk Anomalies in CKD (RCAV) study, which examines risk factors in patients with incident CKD in US veterans, and which was previously described in detail. (Gosmanova et al., 2014 , Molnar et al., 2014a Presence of RLS was identified from the VA Inpatient and Outpatient Medical SAS Datasets using ICD-9-CM diagnostic codes (Table S1 ). The algorithm for cohort definition is shown in Figure 1 . Patients were included in the study if they had a normal kidney functtion defined as a baseline estimated glomerular filtration rate (eGFR) ≥60 ml/min/1.73m 2 and did not have a diagnosis of RLS at the first encounter in the inclusion period (October 1, 2004-September 30, 2006 ) and the follow-up period, while other comorbidities were listed during that encounter. The final cohort included 3,519,773 patients, 3,515,660 patients without RLS and 4,113 incident RLS patients. From this cohort, we created a 1:1 propensity score macthed cohort consisting of 3,696 patients in each group.
Exposure and Covariates
Incident RLS was defined as a new ICD9-CM code for RLS during the inclusion and followup period, without such a diagnosis at the first encounter.
Socio-demographic characteristics, comorbid conditions and laboratory characteristics were obtained, as previously described. ( (Table S2 ). Prevalent comorbidities were defined as those diagnosed during October 1, 2004-September 30, 2006.
Outcomes
We defined four different outcomes: 1) all-cause mortality, 2) incident CHD, 3) incident ischemic stroke, and 4) incidence of CKD.
Data on all-cause mortality was obtained from the VA Vital Status Files (VSF), which contain dates of death or last medical/administrative encounter from all sources in the VA system with sensitivity and specificity of 98.3% and 99.8%, respectively, as compared to the National Death Index. (Arnold N, 2006 ) Incident CHD was defined as the composite outcome of a first occurrence of an ICD-9-CM or CPT code for acute myocardial infarction, coronary artery bypass grafting, or percutaneous angioplasty after October 1, 2006 in patients without such diagnoses prior to this date. Incident stroke was defined as the first occurrence of ICD-9-CM codes for ischemic stroke after October 1, 2006 in patients without such diagnoses prior to this date (Table S3 -S4). Incident CKD was defined as two consecutive eGFR levels <60 ml/min/1.73m 2 separated by ≥90 days, and a >25% decrease from baseline eGFR. Estimated GFR was calculated from serum creatinine measurements using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) Equation. (Levey et al., 2009 ) The diagnosis of RLS was always prior to the diagnosis of outcome. The follow-up time was calculated based on these dates (date of outcome -date of RLS).
Statistical Analysis
Data were summarized using proportions, means ± SD, or median (interquartile range (IQR)) as appropriate. Continuous variables were compared using the Student's t-test and Mann-Whitney U test according to data type. Predictors of incident RLS were assessed using logistic regression analyses. The associations between RLS and outcomes were assessed using the Kaplan-Meier method, and Cox proportional hazard models.
The start of the follow-up period for mortality and incident CKD analyses was the date of the first eGFR ≥60 ml/min/1.73m 2 during October 1, 2004-September 30, 2006. Patients diagnosed with RLS at a subsequent date were considered as part of the non-RLS group for the time period between cohort entry and diagnosis of RLS. Patients were followed until death or incident CKD, or were censored at the date of last healthcare or administrative visit, or on July 26, 2013.
In incident CHD and stroke analyses; incident CHD and stroke events were identified in patients without such diagnoses prior to this date; therefore, to avoid immortal time bias,(Liu et al., 2012) the start of the follow-up period for these end points was October 1, 2006. Patients diagnosed with RLS at a subsequent date were considered as part of the non-RLS group for the time period between October 1, 2006 and the diagnosis of RLS. Patients were followed until the first incident CHD/stroke event or were censored at the date of death, last healthcare or administrative visit, or on July 26, 2013.
The propensity score method was used to account for baseline differences arising from dissimilarities in clinical and demographic characteristics of patients with and without RLS. Variables associated with the presence of RLS were identified using logistic regression and were used to calculate propensity scores. STATA's "psmatch2" command suite was used to generate the propensity score-matched cohorts by a 1-to-1 nearest neighbor matching without replacement. The following variables were included the logictis regression model to create the propensity score: age, gender, race/ethnicity, income, marital status, baseline eGFR, comorbidities at baseline (diabetes, hypertension, cardiovascular disease, heart failure, cerebrovascular disease, peripheral vascular disease, lung disease, dementia, rheumatic disease, malignancy, HIV/AIDS, depression, presence of Obstructive Sleep Apnea (OSA) and presence of Periodic Limb Movements in Sleep (PLMS)) and body mass index (BMI). All associations were examined in unadjusted models using our propensity-matched cohort of 7,392 patients. We performed subgroup analyses for all outcomes. Statistical analyses were performed using Stata MP version 12 (Stata Corporation, College Station, TX).
Results
Baseline characteristics
The mean±SD age of the cohort at baseline was 59.8±14.3 years, 93% were male, 78% and 17% of patients were white and black, respectively, 23% of the patients were diabetic and the mean baseline eGFR was 83.8±15.5 ml/min/1.73m 2 . Baseline characteristics of patients categorized by RLS status are shown in Table 1 . In the original cohort (n=3,519,773) patients with RLS were slightly younger, more likely to be white, divorced and to have lower income, and had higher body mass index (BMI), higher prevalence of hypertension, diabetes mellitus, CVD, congestive heart failure (CHF), cerebrovascular disease, peripheral artery disease, chronic lung disease, and depression. After propensity score matching these differences disappeared and the baseline characteristics of patients with and without RLS were balanced ( Table 1) .
Predictors of RLS
In our adjusted logistic regression model, female gender, white race, lower income, higher BMI and most of the comorbidities (such as diabetes, CVD, peripheral artery disease, chronic lung disease, depression, presence of OSA and presence of PLMS) were associated with a higher risk of incident RLS ( Table 2) . Figure 2 panel A shows the associations between incident RLS and mortality in the propensity-matched cohort. Incident RLS was associated with higher risk of mortality (hazard ratio (HR): 1.88, 95% confidence interval (CI): 1.70-2.08) compared to RLS negative patients (Table 3) . Similar results were found in all subgroups, except in patients with peripheral artery disease and in African-American patients (Figure 3  panel A) . Similar association was found when we adjusted for insomnia in our sensitivity analysis (Table S5 ).
Mortality
Incident CHD
There were 157 incident CHD events (4%, event rate 5.9 [5.1-6.9]/1000 patient-years) in the RLS negative group, and 425 incident CHD events (12%, 22.6 [20.2-25.3]/1000 patientyears) in the RLS positive group in the propensity-matched cohort. Figure 2 panel B shows the associations between incident RLS and incident CHD in the propensity-matched cohort. Incident RLS was associated with higher risk of incident CHD (HR: 3.97, 95%CI: 3.26-4.84) ( Table 3) . Similar results were found in all subgroups, except in patients with BMI≥40 kg/m 2 (Figure 3 panel B) . Similar association was found when we adjusted for insomnia in our sensitivity analysis (Table S5 ).
Incident stroke
There were 104 incident stroke events (3%, event rate 4.0 [3.3-4.9]/1000 patient-years) in the RLS negative group, and 293 incident stroke events (9%, 16.6 [14.5-18.9 ]/1000 patientyears) in the RLS positive group in the propensity-matched cohort. Figure 2 panel C shows the associations between incident RLS and incident stroke in the propensity-matched cohort. Incident RLS was associated with higher risk of incident stroke (HR: 3.89, 95%CI: 3.07-4.94) ( Table 3) . Similar results were found in all subgroups, except patients with BMI ≥40 kg/m 2 (Figure 3 panel C) . Similar association was found when we adjusted for insomnia in our sensitivity analysis (Table S5 ).
Incidence of eGFR <60 ml/min/1.73m 2
There were 503 incident CKD events (14%, event rate 14. Figure 2 panel D shows the associations between incident RLS and incident CKD in the propensity-matched cohort. Incident RLS was associated with higher risk of incident CKD events (HR: 3.17, 95%CI: 2.74-3.66) ( Table 3) . Similar results were found in all subgroups (Figure 3 panel  D) . Similar association was found when we adjusted for insomnia in our sensitivity analysis (Table S5 ).
Discussion
In a large cohort of US veterans with baseline eGFR ≥60 ml/min/1.73m 2 , we examined the association of incident RLS with higher risk of all-cause mortality, incident CHD and stroke, and incident eGFR <60 ml/min/1.73m 2 . Incident RLS was associated with substantially higher risk of all examined clinical outcomes in this well-balanced propensity-matched cohort.
In this large cohort study, incident RLS was associated with an 88% higher risk of mortality during a median 8-year follow-up period. Higher mortality associated with RLS was reported in several previous studies, however, most of these studies used smaller cohorts of RLS patients and the number of events was also small. (Mallon et al., 2008 , Li et al., 2013 Contrary to the findings from these studies and to our results, Szentkiralyi et al. did not find an association between incident RLS and mortality in an analysis of four cohorts; however, only one out of the four cohorts included more than one hundred patients with RLS. Our study is notable for its large sample size and event numbers, and for it being representative of veterans in the entire US. To our knowledge, this is the first large study using a propensity score matched approach to balance measured confounders. In addition, this is the first study to find substantial associations between RLS and incident decrease in eGFR. This study also has several limitations that need to be acknowledged. This being an observational study, we can only report associations, and we cannot claim that incident RLS was indeed the cause of the worse clinical outcomes. Additionally, a propensity score method can only account for the effects of known confounders. Therefore, we cannot rule out residual confounding. Our study is limited by the use of diagnostic codes to define RLS. The diagnostic performance of these codes is not known. However, the significant predictors of incident RLS in our study were similar to those found in previous studies. (Szentkiralyi et al., 2012a) We were unable to assess the associations between the severity of RLS with various outcomes. We also have no data about the treatment of RLS. The study population consisted of mostly male patients; hence, the results may not be generalizable to females, although 7% of our propensity-matched cohort consisted of females. Because we did not have information about causes of death, we could not analyze associations with causespecific mortality. Additionally, we did not have data about albuminuria in our database; consequently we cannot assess the association with properly defined incident CKD.
Conclusions
In our large and contemporary cohort of US veterans, incident RLS was associated with higher risk of mortality, incident CHD, stroke and CKD. Improvement of the diagnostics and early detection as well the effect of proper therapy of RLS on preventing these clinical events needs to be tested in clinical trials. 
